OA
WeChat
Home
About Us
Investor Relations
R & D
Careers
Contact Us
Investor Relations
Corporate Information
Business Overview
Board of Directors,Senior Management and Academic Advisers
Corporate Governance
Financial Information
Shareholdings of Directors and CEO
Financial Reports
Stock Information
Corporate Communications
Announcements & Circulars
Returns on Share Capital
Multimedia
Corporate Presentation
Video
Corporate Pictures
Contact Us
Location:
>
Home
>
Inverstor Relations
>
Corporate Communications
>
Announcements & Circulars
You will need the Adobe Acrobat Reader 7.0 and Asian Font Packs to view the PDF.
If you do not have any of the above, please download
"Acrobat Reader"
and
"Asian Font Packs for Acrobat Reader 7.0"
.
Please select year
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2023-06-02
VOLUNTARY ANNOUNCEMENT - THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION HAS ACCEPTED THE NEW DRUG APPLICATION FOR EBRONUCIMAB INJECTION (ANTI-PCSK9 MONOCLONAL ANTIBODY, AK102) DEVELOPED BY AD PHARMACEUT
2023-05-25
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 25 MAY 2023
2023-04-28
SHARE OPTION SCHEME The document that you are looking for has been removed and is no longer available.
2023-04-25
NOTIFICATION LETTER - NOTICE OF PUBLICATION OF ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2022
2023-04-25
Form of proxy for use at the Annual General Meeting of the Company to be held on Thursday, 25 May 2023 (or at any adjournment thereof)
2023-04-25
NOTICE OF ANNUAL GENERAL MEETING
2023-04-25
PROPOSALS FOR GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES; RE-ELECTION OF DIRECTORS; PROPOSED ADOPTION OF THE NEW SHARE OPTION SCHEME AND TERMINATION OF THE EXISTING SHARE OPTION SCHEME AND NOTICE
2023-03-26
FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2022 AND CLOSURE OF REGISTER OF MEMBERS
2023-03-26
ANNOUNCEMENT OF THE ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2022
2023-03-10
DATE OF BOARD MEETING
Total
29
pages
Current
3
/
29
First
Prev
Next
Last
GO